Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Metabolic Profiling & Lipidomics

Ainara Cano's Biography

Ainara Cano, Research Scientist, One Way Liver (OWL)

Ainara gained her doctorate in the Group “Lipids and Liver” from the University of the Basque Country. Her research is focused on unraveling the physiopathological mechanisms that underlie nonalcoholic fatty-liver disease (NAFLD). At present, she is a researcher in the Biotech Company One Way Liver (OWL), Biscay Science and Technology Park, Spain. The goal that pursues OWL is to find diagnostic and prognostic biomarkers for a variety of liver diseases, such as NAFLD, liver fibrosis and liver cancer and a number of neurological disorders. This is achieved by means of metabolite UPLC-MS analyses and bioinformatics in a plethora of biological materials.

Ainara Cano Image

Nonalcoholic Fatty Liver Disease Diagnosis by Means of Serum Metabolomics

Wednesday, 17 October 2012 at 11:15

Add to Calendar ▼2012-10-17 11:15:002012-10-17 12:15:00Europe/LondonNonalcoholic Fatty Liver Disease Diagnosis by Means of Serum

Diagnosis of the early stages of nonalcoholic fatty-liver disease (NAFLD): steatosis and nonalcoholic steatohepatitis. The pursuit of serum metabolic biomarkers by reverse ultra-performance liquid chromatography coupled to mass spectrometry (UPLC-MS)

Add to Calendar ▼2012-10-16 00:00:002012-10-17 00:00:00Europe/LondonMetabolic Profiling and